
Enzo Biochem (ENZ) P/E Ratio
P/E Ratio as of Aug 6, 2025: -1.71
Average-1.69
Median-1.69
Minimum-1.71
Maximum-1.69
-1.71
Past Month-0.01 (0.59%)
The P/E ratio for Enzo Biochem (ENZ) is -1.71 as of Aug 6, 2025. This represents a increase of 16.33% compared to its 12-month average P/E ratio of -1.47. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Enzo Biochem P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Enzo Biochem’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Enzo Biochem to industry peers.
Enzo Biochem P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Enzo Biochem’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Enzo Biochem to industry peers.
Enzo Biochem (ENZ) P/E Ratio Insights
See Enzo Biochem’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Enzo Biochem (ENZ)
Order type
Buy in
Order amount
Est. shares
0 shares
Enzo Biochem (ENZ) P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Aug 1, 2025 | $0.6825 | -1.69 |
Jul 1, 2025 | $0.681 | -1.69 |
Jun 2, 2025 | $0.5825 | -1.42 |
May 1, 2025 | $0.49 | -1.20 |
Apr 1, 2025 | $0.34 | -0.83 |
Mar 3, 2025 | $0.4851 | -1.10 |
Feb 3, 2025 | $0.5826 | -1.32 |
Jan 2, 2025 | $0.7201 | -1.64 |
Enzo Biochem (ENZ) End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | -1.71 | +5.56% |
2024 | -1.62 | +8.72% |
2023 | -1.49 | -43.13% |
2022 | -2.62 | -108.82% |
2021 | 29.69 | -608.39% |
2020 | -5.84 | — |
FAQs About Enzo Biochem (ENZ) P/E ratio
The latest P/E ratio of Enzo Biochem (ENZ) is -1.71, as of Aug 6, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Enzo Biochem’s last 12-month average P/E ratio is -1.47, compared to its current P/E ratio of -1.71. This reflects a increase of 16.33%.
Enzo Biochem’s current P/E ratio of -1.71 is higher than its last 12-month average P/E of -1.47. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Enzo Biochem’s average P/E ratio over the last 3 years is -2. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Enzo Biochem’s average P/E ratio over the last 5 years is 34.69. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.